Back to discover
Disease
Cholecystitis
Late-stage therapeutic developmentEmerging research
2
Publications
16
Clinical trials
2022
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2022-05-01JAMA internal medicine
Adverse events associated with ERCP.
Research2016-08-18Gastrointestinal endoscopy
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 2 clinical trials expected to report results, the earliest in Q4 2027.
Upcoming Milestones
- Q4 2027Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Patients With Chronic Cholecystitis and Biliary Tract Dyskinesia
- Q4 2027Upfront Endoscopic Ultrasound-guided Gallbladder Drainage (EUS-GBD) Versus Standard Protocol (Antibiotics First) for Mild to Moderate Acute Cholecystitis in Patients Who Are Very-high-risk for Cholecystectomy: A Randomized-controlled Trial.
Major developments
Upcoming trial readoutImportant
Results expected Q4 20272026-05-19
Upcoming trial readoutImportant
Results expected Q4 20272026-04-07
Clinical MilestonesViewHide
Results expected
- 2026-05-19Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Patients With Chronic Cholecystitis and Biliary Tract DyskinesiaResults expected Q4 2027
- 2026-04-07Upfront Endoscopic Ultrasound-guided Gallbladder Drainage (EUS-GBD) Versus Standard Protocol (Antibiotics First) for Mild to Moderate Acute Cholecystitis in Patients Who Are Very-high-risk for Cholecystectomy: A Randomized-controlled Trial.Results expected Q4 2027
Recently completed
Activity timeline4
- 2026-05-19ClinicalMulticenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Patients With Chronic Cholecystitis and Biliary Tract DyskinesiaResults expected Q4 2027
- 2026-04-07ClinicalUpfront Endoscopic Ultrasound-guided Gallbladder Drainage (EUS-GBD) Versus Standard Protocol (Antibiotics First) for Mild to Moderate Acute Cholecystitis in Patients Who Are Very-high-risk for Cholecystectomy: A Randomized-controlled Trial.Results expected Q4 2027
- 2026-03-30ClinicalClinical Study on the Effect of Tegileridine on Postoperative Pain in PatientsUndergoing Abdominal Surgery:A Randomized Controlled Double-blind Trial.Completed
- 2025-12-31ClinicalThe Effect of Sevoflurane and Desflurane Anesthetic Agents Used in Elective Cholecystectomy Surgery on Heme Oxygenase-1 mRNA Expression and Heme Oxygenase-1 Protein Levels: A Comparative Prospective StudyWithdrawn
Clinical trials
The current development programme across all trial phases.
Clinical programme
16
5
11
6
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Publications over time
Most influential
Major themes4
- Antibiotic Prophylaxis1
- Cholecystitis1
- Cholelithiasis1
- Diabetes Mellitus, Type 21
Leading journals2
- Gastrointestinal endoscopy1
- JAMA internal medicine1
Leading researchers8
- Acosta RD1
- Agrawal D1
- Bruining DH1
- Chandrasekhara V1
- DeWitt JM1
- Eloubeidi MA1
- Fanelli RD1
- Faulx AL1
Affiliations (unnormalised)1
- Key Laboratory of Endocrinology of the National Health Commission1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.